Stonvex publishes market data and research only. Not investment advice. Not a registered investment advisor. Read disclaimer.

KWR

Live52w high -22.4%

Annual Quarterly

Core line items from KWR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

Annual Quarterly

Entity: QUAKER CHEMICAL CORPORATION·Source: SEC EDGAR companyfacts·Next-Q consensus from Finnhub

Metric	Q3 2026 (Est.) Expected 2026-07-29	Q1 2026 2026-03-31	Annual 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30
Revenue	$512.49M	$480.48M	$1.89B	$1.42B	$926.31M
Operating Income	Not available	$33.59M	$52.99M	$21.75M	$-24.89M
Net Income	Not available	$19.67M	$-2.49M	$-23.19M	$-53.66M
EPS (Diluted)	$1.68	$1.13	$-0.14	$-1.32	$-3.04
Total Assets	Not available	$2.80B	$2.80B	$2.82B	$2.85B
Total Liabilities	Not available	$1.42B	$1.42B	$1.45B	$1.50B
Cash & Equivalents	Not available	$169.73M	$179.83M	$172.04M	$201.92M
Free Cash Flow OCF − CapEx	Not available	$-6.87M	$80.60M	$56.28M	$18.23M
Shares Outstanding	Not available	17.37M	17.33M	17.37M	17.39M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data. The amber (Est.) column shows Wall Street analyst consensus for the next reporting period — only Revenue and EPS are covered by published consensus, so other line items remain blank. These are third-party estimates, not company guidance.

Core line items from KWR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

52w high -22.4%

Entity: QUAKER CHEMICAL CORPORATION·Source: SEC EDGAR companyfacts·Next-Q consensus from Finnhub

Metric	Q3 2026 (Est.) Expected 2026-07-29	Q1 2026 2026-03-31	Annual 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30
Revenue	$512.49M	$480.48M	$1.89B	$1.42B	$926.31M
Operating Income	Not available	$33.59M	$52.99M	$21.75M	$-24.89M
Net Income	Not available	$19.67M	$-2.49M	$-23.19M	$-53.66M
EPS (Diluted)	$1.68	$1.13	$-0.14	$-1.32	$-3.04
Total Assets	Not available	$2.80B	$2.80B	$2.82B	$2.85B
Total Liabilities	Not available	$1.42B	$1.42B	$1.45B	$1.50B
Cash & Equivalents	Not available	$169.73M	$179.83M	$172.04M	$201.92M
Free Cash Flow OCF − CapEx	Not available	$-6.87M	$80.60M	$56.28M	$18.23M
Shares Outstanding	Not available	17.37M	17.33M	17.37M	17.39M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data. The amber (Est.) column shows Wall Street analyst consensus for the next reporting period — only Revenue and EPS are covered by published consensus, so other line items remain blank. These are third-party estimates, not company guidance.